Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
about
CHLA-136CHLA-15CHLA-151CHLA-20CHLA-253hCHLA-42CHLA-79CHP-134COG-N-261hCOG-N-263COG-N-265COG-N-276hCOG-N-278COG-N-289COG-N-295COG-N-297COG-N-299COG-N-305COG-N-316COG-N-318COG-N-324COG-N-327hCOG-N-328hCOG-N-331COG-N-334COG-N-346hCOG-N-347COG-N-349COG-N-354COG-N-354hCOG-N-367hCOG-N-386hCOG-N-387hIMR-5LA-N-5LA-N-6NB-1643NB16NB69NBL-S
P1343
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancerNCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesTranslational development of difluoromethylornithine (DFMO) for the treatment of neuroblastomaMammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomicsNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Mutational signatures: the patterns of somatic mutations hidden in cancer genomesSWI/SNF chromatin remodeling complexes and cancerTargeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma.Blood-based Tumor Markers in Lung CancerBlood-based analyses of cancer: circulating tumor cells and circulating tumor DNASWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2The SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseasesInactivating CUX1 mutations promote tumorigenesisEssential Roles for ARID1B in Dendritic Arborization and Spine Morphology of Developing Pyramidal NeuronsSignatures of mutational processes in human cancerDetection of circulating tumor DNA in early- and late-stage human malignanciesNeuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.The mutational landscape of chromatin regulatory factors across 4,623 tumor samples.Data on affected cancer-related genes in pediatric t(12;21)-positive acute lymphoblastic leukemia patients harboring unbalanced der(6)t(X;6) translocations.Research progress of neuroblastoma related gene variations.Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastomaCis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis.A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma.An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course.Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.Chromatin-regulating proteins as targets for cancer therapy.Polycomb and trithorax opposition in development and disease.SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma.Ultra-High Density SNParray in Neuroblastoma Molecular DiagnosticsIdentification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.Platform comparison for evaluation of ALK protein immunohistochemical expression, genomic copy number and hotspot mutation status in neuroblastomasSomatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumoursEpigenomic alterations define lethal CIMP-positive ependymomas of infancyMechanisms by which SMARCB1 loss drives rhabdoid tumor growth.De novo mutations in histone-modifying genes in congenital heart disease.The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemiasClinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
P2860
Q54812160-0632FBC3-8919-42B6-BA7D-9785D99249BBQ54812166-B710D76E-09A4-413D-9323-462F6DE64C75Q54812168-76AD12E5-4320-4E4D-8B67-8CF97C9229FDQ54812179-8CA0EBA5-B0F0-486D-9D60-724A04C442C8Q54812491-BE57B6B7-B04E-4456-8D9A-30EC252F7E1DQ54812498-88C444CE-0F3F-49A3-AE98-174778031C08Q54812506-94A0B5EC-A11D-4243-970B-C48AABD8BFF0Q54813265-88315270-E874-4F76-A478-CBB2763825DEQ54813979-399B984C-87BB-4C5C-BEB8-5F4C8F301851Q54813980-A5863C12-2079-47DA-AB97-F69B564EA912Q54813981-023667BB-85AC-401E-A501-CB42D150A05FQ54813982-B3A15FF2-6EE3-4783-B07C-22AD780F249DQ54813983-0ED642F4-5A53-4187-AB7A-9ED43811E020Q54813984-B5B4C6C8-A0F5-47A8-9343-6C09FA1D36E6Q54813987-6B2530C0-B666-4214-AE70-1B894FD84C6FQ54813989-015DC1E8-3E7F-4723-AF44-2C7D22BBF05BQ54813990-E835A159-06A5-4463-B9C7-EC3682EDB9ADQ54813991-805E08E3-562F-426A-A6E0-CF391294B176Q54813992-EFBC86A1-4102-44AF-A451-614DDDC3B7A3Q54813993-9F1FF135-E16E-4143-A28A-E706483645BBQ54813996-16240A92-C211-4084-9ACD-0A18EB2C926EQ54814010-FA70DF96-BE03-4F2F-9C68-50DEEB439EA6Q54814011-C51030A7-444F-482E-B080-85A0A79469F5Q54814012-A1039921-25BD-4C74-8B9B-CF11B1D5D259Q54814013-5DEDB418-9C1D-4C9B-89B3-7E99C11C0D7CQ54814014-5E6ADCB1-13BD-4378-98BD-CFA57EFC03B8Q54814015-275233FB-EF60-4AE2-A116-E947BB326177Q54814016-2017E242-3B73-44C4-A18A-E22168AB9F4EQ54814017-3A4E9281-2DE5-4076-9130-8F75BF9CDCBAQ54814018-D894EBEC-AEBB-4F5D-964B-6308240F1247Q54814019-2DC0696D-6641-4269-84F6-95A5C7FDE883Q54814020-460FD818-CB61-4857-81CD-8772FE610879Q54814021-BBFD3FA5-72EF-4156-9774-B845E05F9F8FQ54897648-DEED94C3-5476-4352-83E2-D763C0DD8C6BQ54901878-9C8E66D4-3B67-45FC-91DB-1BEFC6C5165FQ54901879-7C6C6684-23B8-42F6-A379-14CE1A73270BQ54907501-EB47BDCD-F3F0-496B-AA4A-9B07FE1CF0DAQ54907517-E9BD18F3-9AE4-4EE3-8491-499B5CB43C5FQ54907543-2780F72C-4C48-47CA-AC1C-EDEA1C947A95Q54907552-9CAED175-5AE7-4B17-A2B8-D65D41A5E815
P1343
Q24563539-45D89FD8-1AE9-4993-82DB-0AE050837EC6Q24596715-896F0F18-6938-44FE-A47A-0E73502F3B9CQ26770306-22DB9C3F-B378-44EF-95B8-F6B9B336AAE7Q26776098-99406048-77AB-480A-83E4-40EF7F448984Q26825652-C720456D-C2C5-465C-9F99-DECD3A454BCBQ26827810-692952B5-7F63-4E1C-A5D0-862D05DB283BQ26850125-BC34D6E0-F635-4680-8157-AE689AB60DD5Q26998657-C4E18EBF-3A7C-48CC-BEBB-ECDE5705DA44Q27853330-A3B0B84B-0C9B-4831-8E71-991D90641F09Q28072736-00C09178-A6B6-417E-A4C1-60553110E657Q28239638-5435B44D-1152-427C-BE16-AE9238E5D9FBQ28269618-0FDA6089-AD72-4151-A3DE-14ACAB5D82F9Q28292392-30DB1771-E7F0-49BD-936A-0C5E2054AF0BQ28303563-94C35EF2-1691-4266-AFAA-2582F169A91CQ28510104-6873D8AC-DD67-43C8-82F8-C06FAB6521C0Q29547191-D73C92DA-5422-4E5D-AE15-70ED20B26E8DQ29615778-B88A4A6B-643A-4CA6-9C29-F4835E537DC3Q30239861-2632A2DC-775B-486C-86B1-F790B2DC6995Q30426051-C405F899-8B81-4D70-A09F-C248076711E9Q30580509-0F92C411-16DB-4215-BE0A-A4A9AD84CFD0Q31120836-9B8FED11-F550-4786-BBC1-46AAA49326FBQ33566987-D6B80330-6DB1-4289-BE33-BEC4F2543534Q33578303-D212AB1F-2285-4501-A6C5-845440D04F8BQ33759081-25BA2063-98FD-41A7-AABF-6B208107D07AQ33761625-8BD6FB43-FA55-4CFB-8A1A-B990922E9884Q33865090-44BFDB36-226C-4298-B06D-6DF674F28A9FQ33889856-DE78B0D8-217B-4D6C-9A62-E0BF820A38C0Q33907067-B2C9C0C8-EA2C-4160-AB17-1927601906A8Q33920032-7DEF6A28-4AD4-4463-A9CD-F39B14DC5250Q33923821-054F5E52-5D63-4C0D-80AD-2C25C8BDE29FQ34032495-C6E52E09-07C1-4362-B79B-1B1DCB7E842DQ34038964-8D910349-5476-4E21-829A-18F6DF902E47Q34134105-22574905-7339-4E61-8D8C-C515D2C7CD6CQ34157777-1FE85302-FA2A-43A2-AE35-227D66BBD32EQ34240198-368A6526-3E8B-410A-BB24-846D6D392C96Q34332647-CCF75FD4-CFB5-4291-9B66-EA5CA0E31F63Q34344183-7B1EDF96-373B-425F-AB83-CE320C438ED0Q34465221-CC8C1F43-BCF1-4E29-9CD0-2FE9DF6A0214Q34483980-5A4F6E07-D198-43EA-8BE7-7FDFF3EC0519Q34557699-3B83268D-64C0-4CD1-AAF9-26E6DBBBFD54
P2860
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@ast
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@en
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@nl
type
label
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@ast
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@en
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@nl
prefLabel
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@ast
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@en
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@nl
P2093
P2860
P4510
P50
P3181
P356
P1433
P1476
Integrated genomic analyses id ...... childhood cancer neuroblastoma
@en
P2093
Amanda Blackford
C Patrick Reynolds
Giovanni Parmigiani
Mark Sausen
Michael D Hogarty
Nickolas Papadopoulos
Rebecca J Leary
Xueyuan Liu
P2860
P2888
P3181
P356
10.1038/NG.2493
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1033735592